Cytogenetic profiling of human articular cartilage chondrocytes, fibronectin adhesion assay derived chondroprogenitors and migratory chondroprogenitors.
Benita Mercy Karunya B, Mary Purna Chacko, Ganesh Parasuraman, Abel Livingston, Boopalan Ramasamy, Solomon Sathishkumar, Elizabeth Vinod
{"title":"Cytogenetic profiling of human articular cartilage chondrocytes, fibronectin adhesion assay derived chondroprogenitors and migratory chondroprogenitors.","authors":"Benita Mercy Karunya B, Mary Purna Chacko, Ganesh Parasuraman, Abel Livingston, Boopalan Ramasamy, Solomon Sathishkumar, Elizabeth Vinod","doi":"10.1080/03008207.2025.2548271","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Cartilage-derived chondroprogenitors, with inherent chondrogenic capacity and low hypertrophic potential, represent a promising avenue for cartilage regeneration. For clinical translation, assessment of cellular genomic stability is a quality control mandate. Since culturing cells to higher passage numbers for achieving the cell requirement is indispensable, it is necessary to evaluate the possibility of culture-driven mutations before transplantation. Being a relatively newly discovered cell subset, the information on the genetic profile of these cartilage-resident cells is notably limited.</p><p><strong>Methods: </strong>The study investigated the genomic stability of fibronectin adhesion assay-derived chondroprogenitors(FAA-CP), migratory chondroprogenitors(MCP) and chondrocytes (<i>n</i> = 3). Conventional karyotyping and microarray analysis were performed on early and late passage cells to assess their genomic integrity under standard culture conditions and any groups that showed variations were further evaluated for their tumorigenic potential using the soft-agar assay.</p><p><strong>Results: </strong>Chondrocytes exhibited a higher propensity for culture-induced genetic aberrations, including chromosomal losses, gains, inversions, and translocations. In contrast, both the chondroprogenitor groups demonstrated greater genomic stability throughout culture, with an instance of Trisomy-7 observed in early passage and a loss of gonosome in the later passage MCP group. Microarray analysis of chondroprogenitors showed a normal genomic profile, and soft agar assays indicated a non-tumorigenic profile for all cell groups that showed abnormal cytogenetic profiles.</p><p><strong>Conclusions: </strong>The study highlights the importance of distinguishing between inherent genetic abnormalities and those acquired during culture, particularly when considering cells for therapeutic applications. While the observed genetic variations did not confer tumorigenic potential, careful consideration is essential prior to therapy.</p>","PeriodicalId":10661,"journal":{"name":"Connective Tissue Research","volume":" ","pages":"1-14"},"PeriodicalIF":2.1000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Connective Tissue Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03008207.2025.2548271","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Cartilage-derived chondroprogenitors, with inherent chondrogenic capacity and low hypertrophic potential, represent a promising avenue for cartilage regeneration. For clinical translation, assessment of cellular genomic stability is a quality control mandate. Since culturing cells to higher passage numbers for achieving the cell requirement is indispensable, it is necessary to evaluate the possibility of culture-driven mutations before transplantation. Being a relatively newly discovered cell subset, the information on the genetic profile of these cartilage-resident cells is notably limited.
Methods: The study investigated the genomic stability of fibronectin adhesion assay-derived chondroprogenitors(FAA-CP), migratory chondroprogenitors(MCP) and chondrocytes (n = 3). Conventional karyotyping and microarray analysis were performed on early and late passage cells to assess their genomic integrity under standard culture conditions and any groups that showed variations were further evaluated for their tumorigenic potential using the soft-agar assay.
Results: Chondrocytes exhibited a higher propensity for culture-induced genetic aberrations, including chromosomal losses, gains, inversions, and translocations. In contrast, both the chondroprogenitor groups demonstrated greater genomic stability throughout culture, with an instance of Trisomy-7 observed in early passage and a loss of gonosome in the later passage MCP group. Microarray analysis of chondroprogenitors showed a normal genomic profile, and soft agar assays indicated a non-tumorigenic profile for all cell groups that showed abnormal cytogenetic profiles.
Conclusions: The study highlights the importance of distinguishing between inherent genetic abnormalities and those acquired during culture, particularly when considering cells for therapeutic applications. While the observed genetic variations did not confer tumorigenic potential, careful consideration is essential prior to therapy.
期刊介绍:
The aim of Connective Tissue Research is to present original and significant research in all basic areas of connective tissue and matrix biology.
The journal also provides topical reviews and, on occasion, the proceedings of conferences in areas of special interest at which original work is presented.
The journal supports an interdisciplinary approach; we present a variety of perspectives from different disciplines, including
Biochemistry
Cell and Molecular Biology
Immunology
Structural Biology
Biophysics
Biomechanics
Regenerative Medicine
The interests of the Editorial Board are to understand, mechanistically, the structure-function relationships in connective tissue extracellular matrix, and its associated cells, through interpretation of sophisticated experimentation using state-of-the-art technologies that include molecular genetics, imaging, immunology, biomechanics and tissue engineering.